Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-001839
Filing Date
2008-03-17
Accepted
2008-03-17 17:25:37
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 BENTLEY PHARMACEUTICALS, INC. b68153bpe10vk.htm 10-K 1276386
2 EX-10.17 LETTER AGREEMENT, DATED DECEMBER 13, 2007 (ADOLFO HERRERA MALAGA) b68153bpexv10w17.htm EX-10.17 20535
3 EX-10.21 LETTER AGREEMENT DATED MARCH 17, 2008 (RICHARD P. LINDSAY) b68153bpexv10w21.htm EX-10.21 14088
4 EX-21.1 SUBSIDIARIES b68153bpexv21w1.htm EX-21.1 9051
5 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b68153bpexv23w1.htm EX-23.1 2138
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68153bpexv31w1.htm EX-31.1 8959
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68153bpexv31w2.htm EX-31.2 9149
8 EX-32.1 SECTION 906 CERTIFICATION OF CEO b68153bpexv32w1.htm EX-32.1 4840
9 EX-32.2 SECTION 906 CERTIFICATION OF CFO b68153bpexv32w2.htm EX-32.2 4852
  Complete submission text file 0000950135-08-001839.txt   1351513
Mailing Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833
Business Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833 6036586100
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10581 | Film No.: 08694124
SIC: 2834 Pharmaceutical Preparations